The 64 rating InvestorsObserver gives to Adaptimmune Therapeutics PLC - ADR (ADAP) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 95 percent of stocks in the Healthcare sector, ADAP’s 64 overall rating means the stock scores better than 64 of all stocks.
ADAP has an Overall Score of 64. Find out what this means to you and get the rest of the rankings on ADAP!